Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Open|November 3, 2023
Predictive model for estimating the risk of high-altitude pulmonary edema: a single-centre retrospective outcome-reporting studyYangzong Suona, Luobu Gesang, Zhuoga Danzeng, et al.
Biochemical Genetics|May 24, 2024
Hypermethylation of BMPR2 and TGF-β Promoter Regions in Tibetan Patients with High-Altitude Polycythemia at Extreme AltitudeQuzong Zhaxi, Luobu Gesang, Ju Huang, et al.
Journal of Thoracic Disease|July 14, 2026
Epidemiological patterns of pulmonary hypertension at 3,658 meters: insights from a Tibet plateau retrospective studyQuzhen Gesang, Zhuoga Danzeng, Yangzong Suona, et al.
BMC Medical Informatics and Decision Making|April 18, 2025
A machine learning-based severity stratification tool for high altitude pulmonary edemaLuobu Gesang, Yangzong Suona, Zhuoga Danzeng, et al.
Open Medicine (Warsaw, Poland)|February 23, 2026
Establishing reference intervals for 25 common biochemical analytes in Tibetans living at very high altitudeBai Ci, Yangzong Suona, Zhuoga Danzeng, et al.
High Altitude Medicine & Biology|May 20, 2026
Establishing Early Intervention Thresholds for High-Altitude Polycythemia: Evidence from a Cross-Sectional Study of Tibetan ResidentsZhuoga Danzeng, Luobu Gesang, Yangzong Suona, et al.
Iscience|June 1, 2026
Equivalent low altitude building improves physiological adaptation at high altitudeLuobu Gesang, Yangzong Suona, Zhuoga Danzeng, et al.
Scientific Reports|February 23, 2026
Unveiling key pathways and potential biomarkers for high-altitude hypertension: a pilot multi-omics studyJu Huang, Zhuoga Danzeng, Luobu Gesang, et al.
Frontiers in Public Health|February 6, 2026
Development and validation of a machine learning based early warning scoring system for high altitude polycythemiaYangzong Suona, Zhuoga Danzeng, Luobu Gesang, et al.
High Altitude Medicine & Biology|September 16, 2025
Efficacy and Safety of Extended-Release Acetazolamide Capsules for the Prevention of Acute Mountain Sickness: A Randomized, Double-Blind, Placebo-Controlled Phase III TrialZhuoga Danzeng, Rui Zhang, Luobu Gesang, et al.
Pageof 1